ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,260Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 122

$635K Total Retail Price of All Prescriptions

Rank: 7 out of 122

330 Patients Receiving at Least One Drug in Part D
56%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Vermont
Lower avg

Schedule Two
Controlled Substances

22% of this provider’s 330 patients filled at least one prescription for a schedule two drug, compared to an average of 10%.

Schedule Three
Controlled Substances

18% of this provider’s 330 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 4,819 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$77 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Vermont
FUROSEMIDE 297 233 1 5
SIMVASTATIN 238 156 2 1
LISINOPRIL 233 125 3 2
HYDROCODONE-ACETAMINOPHEN 216 52 S3 4 16
OMEPRAZOLE 204 100 5 3
HYDROCHLOROTHIAZIDE 198 109 6 6
LEVOTHYROXINE SODIUM 193 149 7 4
SUBOXONE 183 0 8 48
ZOLPIDEM TARTRATE 158 103 9 19
OXYCODONE-ACETAMINOPHEN 158 40 S2 9 41
ATENOLOL 138 97 11 10
AMLODIPINE BESYLATE 138 132 11 7
TRAMADOL HCL 134 105 13 20
IBUPROFEN 125 57 14 68
PROAIR HFA 120 48 15 31
GABAPENTIN 118 67 16 12
ALLOPURINOL 108 91 17 33
METOPROLOL TARTRATE 102 78 18 8
ENDOCET 89 16 S2 19 141
LOSARTAN POTASSIUM 87 73 20 17
MORPHINE SULFATE ER 87 0 S2 20 42
TRAZODONE HCL 85 15 22 21
CITALOPRAM HBR 80 25 23 15
METFORMIN HCL 78 54 24 14
WARFARIN SODIUM 75 71 25 9
BUPRENORPHINE HCL 73 0 S3 26 145
CYCLOBENZAPRINE HCL 72 21 R 27 93
CRESTOR 70 45 28 37
BUPROPION HCL SR 68 45 29 105
AZITHROMYCIN 66 41 30 53
NEXIUM 66 50 30 32
DONEPEZIL HCL 65 53 32 25
TAMSULOSIN HCL 64 54 33 26
SERTRALINE HCL 64 50 33 18
OXYCODONE HCL 63 0 S2 35 30
AMITRIPTYLINE HCL 63 22 R 35 72
XOPENEX HFA 60 33 37 157
CELEBREX 58 55 38 52
SPIRIVA 56 33 39 29
LYRICA 56 19 39 95
NAMENDA 54 49 41 65
HYDROXYZINE HCL 53 0 R 42 165
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 8, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.